课题基金 / 基金详情

Analysis and design of protein interactions that regulate cell death

Analysis and design of protein interactions that regulate cell death
调节细胞死亡的蛋白质相互作用的分析和设计
批准号:
10018034
负责人:
AMY E KEATING
金额:
$31.22万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-01 至 2022-08-31

项目摘要

项目成果

AMY E KEATING的其他基金

相似基金

相关文献

中文摘要
翻译
蛋白质-蛋白质相互作用控制着对人类健康至关重要的无数生物过程。工具 发现、预测和设计这种相互作用可以提供对生物机制的深入了解 并强调治疗干预的可能途径。该项目将整合计算和 实验方法,以促进我们的理解之间的关系序列和 在Bcl-2家族蛋白之间的蛋白质相互作用中起作用。Bcl-2家族调节细胞凋亡, 自噬通过形成特定的复合物,其中一些抑制和其中一些促进细胞死亡。 促凋亡和抗凋亡Bcl-2家族蛋白与短α螺旋结合的竞争 由Bcl-2同源性3(BH 3)基序编码的基因控制关键的细胞存活决定。现在得到确认的 肽和小分子可以模拟或抑制BH 3的相互作用。这样的分子提供了一种 使用外源性试剂控制信号传导结果,如第一种批准用于 通过靶向Bcl-2治疗癌症。尽管取得了令人兴奋的进展,但关于Bcl-2蛋白的开放问题 与BH 3基序的相互作用提供了额外的发现机会。特别是:目前为止 人类蛋白质组中未发现的含BH 3基序的蛋白质通过Bcl-2影响信号传导 家族蛋白质?为什么一些含有BH 3基序的蛋白质会通过以下方式触发线粒体孔的形成? 促凋亡巴克和BAX,而其他人没有?BH 3结合诱导细胞凋亡的机制是什么 导致线粒体膜孔形成和细胞死亡的构象变化?什么 存在使用设计的肽或蛋白质来促进或阻断这种过程的机会吗? 这些问题的答案将影响Bcl-2通路的分析,这对多个人类 疾病,提供新的试剂,并指导癌症和其他疾病的治疗方法的发展。 在上一个资助期取得的巨大成功的基础上,我们将推动 在这些领域取得进展,采用新的方法,将相互作用筛选与结构 建模和预测。我们将应用新的计算方法来预测新的Bcl-2结合 合作伙伴,测试我们的模型的预测,并突出候选的新的相互作用伙伴的生物 意义我们将提出巴克和BAX激活的分子机制,并使用 BH 3基序变体的文库。我们将应用新的计算设计方法来制造肽, 激活或抑制巴克和BAX介导的细胞死亡的小蛋白。我们的共同贡献将 提供了BH 3基序的序列-功能图谱,这是控制基因表达的关键因素。 细胞存活在这项工作中开发的方法和工具也将有助于发现和 抑制其他蛋白质-蛋白质相互作用。 !
英文摘要
Protein-protein interactions control myriad biological processes important for human health. Tools for discovering, predicting and designing such interactions can provide insights into biological mechanisms and highlight possible routes to therapeutic intervention. This project will integrate computational and experimental approaches to advance our understanding of the relationships between sequence and function for protein interactions among Bcl-2 family proteins. The Bcl-2 family regulates apoptosis and autophagy by forming specific complexes, some of which inhibit and some of which promote cell death. Competition between pro- and anti-apoptotic Bcl-2 family proteins for binding to short alpha helices encoded by a Bcl-2 homology 3 (BH3) motif controls key cell survival decisions. It is now well established that peptides and small molecules can mimic or inhibit BH3 interactions. Such molecules provide a way to control signaling outcomes using exogenous reagents, as demonstrated by the first drug approved for treating cancer by targeting Bcl-2. Despite exciting progress, open questions about Bcl-2 protein interactions with BH3 motifs provide additional opportunities for discovery. In particular: Do as-yet undiscovered BH3 motif-containing proteins in the human proteome influence signaling through Bcl-2 family proteins? Why do some proteins that contain BH3 motifs trigger mitochondrial pore formation by pro-apoptotic BAK and BAX whereas others do not? What are the mechanisms of BH3 binding-induced conformational changes that lead to mitochondrial membrane pore formation and cell death? What opportunities exist for promoting or blocking such processes using designed peptides or proteins? Answers to these questions will impact analysis of Bcl-2 pathways important for multiple human diseases, provide new reagents, and guide development of therapies for cancer and other diseases. Building on the substantial successes that we realized in the previous funding period, we will drive progress in these areas by applying new methodology that integrates interaction screening with structural modeling and prediction. We will apply novel computational methods for predicting new Bcl-2 binding partners, test predictions of our models, and highlight candidate new interaction partners of biological significance. We will propose molecular mechanisms of BAK and BAX activation and test them using libraries of BH3 motif variants. We will apply new computational design methods to make peptides and mini-proteins that activate or inhibit BAK and BAX-mediated cell death. Collectively, our contributions will provide a map of the sequence-function landscape of BH3 motifs, which are critical factors controlling cell survival. The methods and tools developed in this work will also be useful for discovering and inhibiting other protein-protein interactions. !
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jmb.2014.09.030
发表时间: 2015-03-27
期刊: JOURNAL OF MOLECULAR BIOLOGY
影响因子: 5.6
作者: [Dutta, Sanjib, Ryan, Jeremy, Chen, T. Scott, Kougentakis, Christos, Letai, Anthony, Keating, Amy E.]
通讯作者: Keating, Amy E.
DOI: 10.1016/j.virusres.2015.10.007
发表时间: 2016-01-04
期刊: Virus research
影响因子: 5
作者: [Burrer CM, Foight GW, Keating AE, Chan GC]
通讯作者: Chan GC
Designing helical peptide inhibitors of protein-protein interactions.
设计蛋白质 - 蛋白质相互作用的螺旋肽抑制剂。
DOI: 10.1016/j.sbi.2016.04.001
发表时间: 2016-08
期刊: Current opinion in structural biology
影响因子: 6.8
作者: [Rezaei Araghi R, Keating AE]
通讯作者: Keating AE
DOI: 10.1021/acschembio.5b01002
发表时间: 2016-05-20
期刊: ACS chemical biology
影响因子: 4
作者: [Rezaei Araghi R, Ryan JA, Letai A, Keating AE]
通讯作者: Keating AE
Computational and Experimental Investigation and Design of Protein Interaction Specificity
Mapping, modeling and manipulating the interactions of protein domains that bind short linear motifs
Mapping, modeling and manipulating the interactions of protein domains that bind short linear motifs
Computationally guided design of helical peptide interaction reagents
海外基金